Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells

被引:78
作者
Yang, Shihe [1 ]
Zhou, Qiong [1 ]
Yang, Xiaohe [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2007年 / 1773卷 / 06期
关键词
genistein; Caspase-3; apoptosis; breast cancer; MCF-7; MDA-MB-231;
D O I
10.1016/j.bbamcr.2007.03.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genistein, a soy isoflavone with anti-tumor properties, has both estrogenic and non-estrogenic activities. Genistein sensitive/estrogen receptor negative (ER-) MDA-MB-231 cells and genistein resistant/ER+MCF-7 cells are frequently cited as examples of differential responses to genistein due to different ER status. Other factors that may affect genistein response, however, are largely unknown. Based on our finding that MCF-7 is caspase-3 deficient, we examined whether caspase-3 status plays a role in the differential responses between the two cell lines. We demonstrate that reconstitution of caspase-3 significantly sensitizes MCF-7 cells to genistein. Specific knockdown of caspase-3 in MDA-MB-231 cells renders the cells resistant to genistein. We also found that caspases-4 and - 10 were downregulated in MCF-7 cells. Reconstitution of caspase- 10 in MCF-7 cells, however, resulted in little sensitization. Moreover, we show that caspase-3 downregulation is very common in breast cancer cell lines and tumor tissues. Taken together, our data indicate that caspase-3 is a critical determinant of cellular response to genistein, which may have important implications in studying soy/genistein-mediated anti-tumor activities. (c) 2007 Elsevier BY. All rights reserved.
引用
收藏
页码:903 / 911
页数:9
相关论文
共 51 条
  • [1] Biomarkers of apoptosis:: Release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene
    Abu-Qare, AW
    Abou-Donia, MB
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2001, 4 (03): : 313 - 332
  • [2] BARNES S, 1995, J NUTR, V125, pS777, DOI 10.1093/jn/125.3_Suppl.777S
  • [3] Differences between human breast cell lines in susceptibility towards growth inhibition by genistein
    Dampier, K
    Hudson, EA
    Howells, LM
    Manson, MM
    Walker, RA
    Gescher, A
    [J]. BRITISH JOURNAL OF CANCER, 2001, 85 (04) : 618 - 624
  • [4] Genistein inhibits NF-κB activation in prostate cancer cells
    Davis, JN
    Kucuk, O
    Sarkar, FH
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1999, 35 (02): : 167 - 174
  • [5] de Lemos ML, 2001, ANN PHARMACOTHER, V35, P1118, DOI 10.1345/aph.10257
  • [6] Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
    Devarajan, E
    Sahin, AA
    Chen, JS
    Krishnamurthy, RR
    Aggarwal, N
    Brun, AM
    Sapino, A
    Zhang, F
    Sharma, D
    Yang, XH
    Tora, AD
    Mehta, K
    [J]. ONCOGENE, 2002, 21 (57) : 8843 - 8851
  • [7] Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro
    Fioravanti, L
    Cappelletti, V
    Miodini, P
    Ronchi, E
    Brivio, M
    Di Fronzo, G
    [J]. CANCER LETTERS, 1998, 130 (1-2) : 143 - 152
  • [8] Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo
    Fujita, E
    Egashira, J
    Urase, K
    Kuida, K
    Momoi, T
    [J]. CELL DEATH AND DIFFERENTIATION, 2001, 8 (04) : 335 - 344
  • [9] Apaf-1 is a mediator of E2F-1-induced apoptosis
    Furukawa, Y
    Nishimura, N
    Furukawa, Y
    Satoh, M
    Endo, H
    Iwase, S
    Yamada, H
    Matsuda, M
    Kano, Y
    Nakamura, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39760 - 39768
  • [10] He Fu-jin, 2002, Zhongguo Zhongyao Zazhi, V27, P936